Haoma Medica Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Investors
  • 1

Haoma Medica General Information

Description

Developer of a biotechnological medicine intended to offer treatment of Osteoporosis and Osteopenia as well as blood clotting management. The company's medicines include a novel class of compound that has a new mechanism of action compared with existing treatments and is designed for low dose oral administration which offers preservation of both bone mass and bone architecture, enabling healthcare professionals to preserve bone integrity of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Care of London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Haoma Medica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) Upcoming Generating Revenue
2. Later Stage VC 04-Aug-2017 00.000 00.000 00.00 Completed Generating Revenue
1. Later Stage VC (Series A) 25-Nov-2016 $955K $955K 00.000 Completed Generating Revenue
To view Haoma Medica’s complete valuation and funding history, request access »

Haoma Medica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 00.000
To view Haoma Medica’s complete cap table history, request access »

Haoma Medica Executive Team (6)

Name Title Board Seat Contact Info
Stephen Deacon Chief Executive Officer, Chief Development Officer & Board Member
Carmen Greco Co-Founder, Chief Financial Officer, Managing Director & Board Member
Stephen Hodges Co-Founder, Chief Scientific Officer & Chairman
Robin Soper Co-Founder, HM Principal Scientist & Scientific Board Member
Cenk Oguz Co-Founder, Chief Medical Officer, Managing Director & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Haoma Medica Board Members (6)

Name Representing Role Since
Carmen Greco Haoma Medica Co-Founder, Chief Financial Officer, Managing Director & Board Member 000 0000
Cenk Oguz Haoma Medica Co-Founder, Chief Medical Officer, Managing Director & Board Member 000 0000
Robin Soper Haoma Medica Co-Founder, HM Principal Scientist & Scientific Board Member 000 0000
Stephanie Eltz MD Self Board Member 000 0000
Stephen Hodges Haoma Medica Co-Founder, Chief Scientific Officer & Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Haoma Medica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Haoma Medica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Silkweed Limited Corporation Minority 000 0000 000000 0
To view Haoma Medica’s complete investors history, request access »